Local therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors Meeting Abstract


Authors: Yu, H. A.; Sima, C. S.; Drilon, A. E. D.; Varghese, A. M.; Pietanza, M. C.; Azzoli, C. G.; Rizvi, N. A.; Krug, L. M.; Kris, M. G.; Miller, V. A.; Riely, G. J.
Abstract Title: Local therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors
Meeting Title: 48th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 30
Issue: 15 Suppl.
Meeting Dates: 2012 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2012-05-20
Language: English
ACCESSION: WOS:000318009804213
PROVIDER: wos
DOI: 10.1200/jco.2012.30.15_suppl.7527
Notes: Meeting Abstract: 7527 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Camelia S Sima
    212 Sima
  2. Lee M Krug
    178 Krug
  3. Christopher G Azzoli
    111 Azzoli
  4. Helena Alexandra Yu
    285 Yu
  5. Anna Mary Varghese
    146 Varghese
  6. Naiyer A Rizvi
    166 Rizvi
  7. Maria C Pietanza
    122 Pietanza
  8. Vincent Miller
    270 Miller
  9. Gregory J Riely
    602 Riely
  10. Mark Kris
    870 Kris
  11. Alexander Edward Drilon
    634 Drilon